CAPECCHI, PIER LEOPOLDO
 Distribuzione geografica
Continente #
NA - Nord America 8.631
EU - Europa 7.302
AS - Asia 1.270
SA - Sud America 17
OC - Oceania 14
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 17.249
Nazione #
US - Stati Uniti d'America 8.605
GB - Regno Unito 2.343
IE - Irlanda 1.307
CN - Cina 921
IT - Italia 831
SE - Svezia 779
UA - Ucraina 680
DE - Germania 510
FR - Francia 391
FI - Finlandia 202
VN - Vietnam 135
RU - Federazione Russa 97
SG - Singapore 83
ES - Italia 45
IN - India 40
BE - Belgio 34
TR - Turchia 29
CA - Canada 22
CZ - Repubblica Ceca 21
TH - Thailandia 18
NL - Olanda 15
AU - Australia 12
IR - Iran 10
GR - Grecia 9
BR - Brasile 8
EU - Europa 7
IL - Israele 7
PL - Polonia 5
HK - Hong Kong 4
HR - Croazia 4
JP - Giappone 4
SK - Slovacchia (Repubblica Slovacca) 4
CH - Svizzera 3
CL - Cile 3
EG - Egitto 3
MK - Macedonia 3
PK - Pakistan 3
AM - Armenia 2
AT - Austria 2
BG - Bulgaria 2
DK - Danimarca 2
IM - Isola di Man 2
KG - Kirghizistan 2
LV - Lettonia 2
MA - Marocco 2
NZ - Nuova Zelanda 2
PE - Perù 2
PH - Filippine 2
RO - Romania 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BO - Bolivia 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
FK - Isole Falkland (Malvinas) 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HU - Ungheria 1
ID - Indonesia 1
JM - Giamaica 1
JO - Giordania 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LT - Lituania 1
MX - Messico 1
NG - Nigeria 1
NP - Nepal 1
PA - Panama 1
PT - Portogallo 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 17.249
Città #
Southend 2.190
Fairfield 1.433
Dublin 1.282
Ashburn 752
Chandler 691
Woodbridge 673
Jacksonville 548
Wilmington 535
Houston 527
Seattle 505
Cambridge 463
Ann Arbor 363
Menlo Park 358
Siena 356
Princeton 242
Beijing 223
Nanjing 201
Dong Ket 135
Dearborn 108
Boardman 105
Helsinki 95
San Diego 93
San Mateo 88
New York 86
Nanchang 73
Moscow 59
Florence 51
Shenyang 51
Shanghai 50
Singapore 49
Málaga 39
Brussels 34
Düsseldorf 34
Hebei 31
Tianjin 30
Changsha 26
Kunming 26
Izmir 25
Lancaster 24
London 24
Jiaxing 23
Norwalk 23
Jinan 22
Falls Church 21
San Francisco 21
Guangzhou 20
Hefei 18
Toronto 18
Fremont 15
Washington 15
Lappeenranta 14
Rome 14
Venezia 14
Brno 13
Pune 13
Zhengzhou 13
Chicago 12
Los Angeles 12
Caserta 11
Mestre 11
Milan 11
Ningbo 11
Redwood City 11
Hangzhou 10
Changchun 9
Lanzhou 9
Munich 9
Paris 8
Pisa 8
Taizhou 8
Tappahannock 8
Fuzhou 7
Hounslow 7
Olomouc 7
Phoenix 7
Sacramento 7
Aulla 6
Canberra 6
Delhi 6
Kilburn 6
Auburn Hills 5
Petah Tikva 5
Rufina 5
São Paulo 5
Turin 5
Zanjan 5
Amsterdam 4
Bari 4
Bratislava 4
Campi Bisenzio 4
Grosseto 4
Modena 4
New Bedfont 4
Queens 4
Sinalunga 4
Zagreb 4
Anguillara Sabazia 3
Arezzo 3
Ascoli Piceno 3
Athens 3
Totale 13.244
Nome #
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes 277
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 240
Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts 231
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 227
Proton pump inhibitors and serum magnesium levels in patients with Torsades de Pointes 224
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system 221
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 213
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. 212
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 204
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 202
Antiarrhythmic potential of anti-cytokine therapy in rheumatoid arthritis: Tocilizumab reduces QTc interval by controlling systemic inflammation. 202
Torsades de Pointes in patients with polymyalgia rheumatica 197
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 195
Spotlight on sirukumab for the treatment of rheumatoid arthritis: The evidence to date 190
Antirheumatic agents in covid-19: is IL-6 the right target? 182
Polyneuropathy with demyelinating changes in Churg–Strauss syndrome: an unusual association 181
Peripheral biomarkers' panel for severe COVID-19 patients 180
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 177
Adenosine receptors expression in cardiac fibroblasts of patients with left ventricular dysfunction due to valvular disease 175
Levels of circulating CXCR4-positive cells are decreased and negatively correlated with risk factors in cardiac transplant recipients 173
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis 173
Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6–Mediated Changes in Connexin Expression 173
Induction of autoimmune response to the extracellular loop of the HERG channel pore induces QTc prolongation in guinea-pigs 169
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 165
Pleuroparenchymal fibroelastosis (PPFE) associated with giant cell arteritis: A coincidence or a novel phenotype? 165
Connective tissue diseases and cardiac rhythm disorders: an overview 157
Statins and the joint: multiple targets for a global protection? 156
Isolated atrioventricular block of unknown origin in the adult and autoimmunity: Diagnostic and therapeutic considerations exemplified by 3 anti-Ro/SSA-associated cases 155
Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls 155
Risk factors for hospital readmission of elderly patients 152
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 151
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 147
The role of P2X7 receptors in tissue fibrosis: a brief review 147
Isolated atrioventricular block of unknown origin in adults and anti-Ro/SSA antibodies: Clinical evidence, putative mechanisms, and therapeutic implications 147
Cyclosporin and tacrolimus increase plasma levels of adenosine in kidney transplanted patients 146
Autoimmune and inflammatory K+ channelopathies in cardiac arrhythmias: Clinical evidence and molecular mechanisms 146
Simvastatin inhibits T cell activation by selectively impairing the function of RAS superfamily GTPases 145
Early and delayed increase in plasma homocysteine levels in heart transplanted patients. 144
Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. 144
Heart failure and chronic kidney disease in a registry of internal medicine wards 142
Allopurinol prevents ischaemia-dependent haemorheological changes 142
Pharmacokinetics and pharmacodynamics of neutrophil-associated ciprofloxacin in humans 140
Pravastatin treatment-associated reduction in plasma homocysteine in heart-transplanted patients. 140
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation 140
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010 139
The "Invulnerability" of the Adult Conduction System to Anti-Ro/SSA Antibodies? A Matter of Calcium Channel Expression on the Cardiomyocyte 139
Ultrasound measurement of rectus femoris muscle thickness as a quick screening test for sarcopenia assessment 138
Using peripheral blood mononuclear cells to determine proteome profiles in human cardiac failure. 136
Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad 136
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 136
Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis 136
Inflammatory cytokines, life-threatening arrhythmias and premature mortality in chronic inflammatory arthritis: Time to focus on 135
Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias 135
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 134
Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. 132
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 131
Autoimmune Calcium Channelopathies and Cardiac Electrical Abnormalities 130
Development and preliminary validation of a diagnostic score for identifying patients affected with adult-onset autoinflammatory disorders 130
One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies 129
Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome 128
Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment. 128
The effects of age and hyperhomocysteinemia on the redox forms of plasma thiols 127
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 126
null 126
Homocysteine and Raynaud’s phenomenon: a review 126
Acute effects of glibenclamide on reactive hyperaemia in the lower limbs in humans. 124
Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer. 124
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 124
Familial Mediterranean fever diagnosed in an elderly patient 122
null 122
null 122
Anti-Ro/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses 121
null 120
Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies 119
Statins as a new therapeutic perspective in myocarditis and postmyocarditis dilated cardiomyopathy 118
Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk 117
Serial KL-6 measurements in COVID-19 patients 117
Human rheumatoid synoviocytes express functional P2X7 receptors 116
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes 116
Cardiac arrest risk during acute infections: systemic inflammation directly prolongs QTc interval via cytokine-mediated effects on potassium channel expression 115
Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts 114
Emerging arrhythmic risk of autoimmune and inflammatory cardiac channelopathies 114
Proton pump inhibitors directly block hERG-potassium channel and independently increase the risk of QTc prolongation in a large cohort of US Veterans 114
Comment on: Letter to the Editor from Clockaerts and Bierma-Zeinstra 113
Pathogenesis of the novel autoimmune-associated long-QT syndrome 113
Potassium Channel Block and Novel Autoimmune-Associated Long QT Syndrome 113
Priming for Pandemic Influenza: Antigen-sparing MF59™-adjuvanted A/H5N1 Vaccine Induces Immunological Memory and Shows Cross-Reactive Potential in Adults Including the Elderly 111
Adenosine A2(A) receptor gene polymorphism (1976C > T) affects coronary flow reserve response during vasodilator stress testing in patients with non ischemic-dilated cardiomyopathy 110
Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation 110
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A oral echocardiographic study 108
Photopheresis immunomodulation after heart transplantation. 107
Long QT Syndrome: An Emerging Role for Inflammation and Immunity 107
Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology) 107
Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, cross-over study in patients with chronic arthritis 106
null 105
Simvastatin reduces MMP-3 level in interleukin 1b-stimulated human chondrocyte culture 104
Surveillance for severe acute respiratory infections among hospitalized subjects from 2015/2016 to 2019/2020 seasons in tuscany, Italy 104
Inhibition of microsomal glucose-6-phosphate transport in human neutrophils results in apoptosis: a potential explanation for neutrophil dysfunction in glycogen storage disease type 1b 103
Homocysteine and P wave dispersion in patients with heart transplantation 102
Primary subcutaneous zygomycosis due to Rhizopus oryzae in a 71-year-old man with normal immune status 100
Totale 14.483
Categoria #
all - tutte 53.563
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.563


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.785 418 134 227 543 230 356 423 476 313 331 124 210
2020/20213.042 134 257 92 352 169 340 201 365 321 284 254 273
2021/20222.192 159 283 133 169 159 74 130 96 138 195 220 436
2022/20232.560 161 250 366 373 204 501 74 187 265 55 68 56
2023/20242.219 93 48 176 111 110 613 686 54 26 62 61 179
2024/202579 79 0 0 0 0 0 0 0 0 0 0 0
Totale 17.563